AMIX
Autonomix Medical, Inc. Common Stock
NASDAQ · Healthcare · Medical - Devices · US
$4.59
−1.92%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
Market Cap
$4.46M
MomentumView details →
1D Return
−1.92%
YTD Return
−60.69%
RSI (14)
42.8
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
Market Cap
$4.46M
RSI (14)
42.8
MomentumView details →
1D Return
−1.92%
YTD Return
−60.69%
SummaryUpdated Jun 1, 2026
Autonomix Medical, Inc. (NASDAQ:AMIX) is a development-stage medical device company founded in 2014 and based in The Woodlands, Texas. The company went public in January 2024 and focuses on developing innovative technologies for sensing and treating disorders related to the peripheral nervous system. As a pre-revenue company, Autonomix is currently in the research and development phase, working to advance its proprietary catheter-based sensing technology platform.
Similar companies
Latest newsMore news →
Autonomix Medical entered into a warrant inducement agreement with an investor for the immediate exercise of existing warrants to purchase 857,462 shares at $5.75 per share, expecting gross proceeds of approximately $4.9 million, and will issue new Series E-1 and E-2 warrants for 1.07 million shares.11d agoAutonomix Medical entered into a warrant inducement agreement for the immediate exercise of outstanding warrants priced at-the-market under Nasdaq rules.53d ago